Gilead Sciences, Inc.
Short

Way overbot, way too extended, way too vulnerable.

74
Yes, yes, I know, this is now longer even a growth story, it's a value play. It has a very low multiple comparing to its peers. I'm sure it has a lot more room to run in the future. But right now, it looks like a sweet short from here.

Clause de non-responsabilité

Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.